2007 Surveillance Slides

Return to 2007 Surveillance Slides Main Menu

Slide 27. Completion of TB Therapy, United States, 1993–2005. The reporting areas began providing infor-mation on completion of therapy in 1993 through the individual TB case report form. The calculations exclude patients with an initial isolate resistant to rifampin as well as children with meningeal, bone or joint, or miliary disease. Overall completion of therapy has remained at approximately 92% from 1998 through 2005. Comple-tion in 1 year or less increased from 64% in 1993 to approximately 83% in 1998—2005, the latest year with available data. The current DHHS Healthy People 2010 objective is completion of therapy in 1 year or less in 90% of patients. CDC is working with state and local health departments to determine and evaluate reasons for apparently delayed completion of therapy, which may vary by jurisdiction.

Back to 2007 Surveillance Slides Main Page

Last Modified: 09/16/2008

Last Reviewed: 05/18/2008
Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

You will need Adobe Acrobat™ Reader v5.0 or higher to read pages that are in PDF format. Download the Adobe Acrobat™ Reader.

If you have difficulty accessing any material on the DTBE Web site because of a disability, please contact us in writing or via telephone and we will work with you to make the information available.

Division of Tuberculosis Elimination
Attn: Content Manager, DTBE Web site
Centers for Disease Control and Prevention
1600 Clifton Rd., NE Mailstop E-10
Atlanta, GA 30333
CDC-INFO at (1-800) 232-4636
TTY: 1 (888) 232-6348
E-mail: tbinfo@cdc.gov

Centers for Disease Control & Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Please send comments/suggestions/requests to: CDCINFO@cdc.gov